BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 7620474)

  • 1. Gastrointestinal symptoms and disorders in patients with eating disorders.
    Sato Y; Fukudo S
    Clin J Gastroenterol; 2015 Oct; 8(5):255-63. PubMed ID: 26499370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent.
    Devlin MJ; Kissileff HR; Zimmerli EJ; Samuels F; Chen BE; Brown AJ; Geliebter A; Walsh BT
    Physiol Behav; 2012 May; 106(2):238-42. PubMed ID: 22361261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment for anorexia nervosa: efficacy, safety, and adherence.
    Bodell LP; Keel PK
    Psychol Res Behav Manag; 2010; 3():91-108. PubMed ID: 22110333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eating disorders in children and adolescents: pharmacological therapies.
    Kotler LA; Walsh BT
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I108-16. PubMed ID: 11140774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection, evaluation, and treatment of eating disorders the role of the primary care physician.
    Walsh JM; Wheat ME; Freund K
    J Gen Intern Med; 2000 Aug; 15(8):577-90. PubMed ID: 10940151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cisapride on antroduodenal co-ordination and gastric emptying.
    Johnson AG
    Scand J Gastroenterol Suppl; 1989; 165():36-43. PubMed ID: 2690323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride.
    Stacher G; Abatzi-Wenzel TA; Wiesnagrotzki S; Bergmann H; Schneider C; Gaupmann G
    Br J Psychiatry; 1993 Mar; 162():398-402. PubMed ID: 8453437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different dosage schedules of cisapride on gastric emptying in idiopathic gastroparesis.
    Corinaldesi R; Stanghellini V; Tosetti C; Rea E; Corbelli C; Marengo M; Monetti N; Barbara L
    Eur J Clin Pharmacol; 1993; 44(5):429-32. PubMed ID: 8359178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.
    Stacher G; Bergmann H; Wiesnagrotzki S; Kiss A; Schneider C; Mittelbach G; Gaupmann G; Höbart J
    Gastroenterology; 1987 Apr; 92(4):1000-6. PubMed ID: 3556983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
    Abell TL; Camilleri M; DiMagno EP; Hench VS; Zinsmeister AR; Malagelada JR
    Dig Dis Sci; 1991 May; 36(5):616-20. PubMed ID: 2022163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric emptying and bloating in anorexia nervosa.
    Lee S
    Br J Psychiatry; 1993 Jul; 163():128-9. PubMed ID: 8353690
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of cisapride in anorexia nervosa.
    Szmukler GI; Young GP; Miller G; Lichtenstein M; Binns DS
    Int J Eat Disord; 1995 May; 17(4):347-57. PubMed ID: 7620474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride.
    Champion MC
    Scand J Gastroenterol Suppl; 1989; 165():44-52; discussion 52-3. PubMed ID: 2690324
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.